Bioethics, Ltd. (BOTH) Financial Statements (2024 and earlier)

Company Profile

Business Address 1661 LAKEVIEW CIRCLE
OGDEN, UT 84403
State of Incorp. NV
Fiscal Year End December 31
Industry (SIC) 677 - Blank Checks (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2957346678,76131,6981,724
Cash and cash equivalents2957346678,76131,6981,724
Receivables     1,500500
Other undisclosed current assets     (1,500)1,500
Total current assets:2957346678,76131,6983,724
Noncurrent Assets
Property, plant and equipment  1,4291,4291,429  
Other undisclosed noncurrent assets  (1,429)(1,203)(917)7981,083
Total noncurrent assets:   2265127981,083
TOTAL ASSETS:2957348939,27332,4964,807
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities179,444138,21692,44657,70511,670 
Accounts payable100,26579,60153,94337,783  
Accrued liabilities79,17958,61538,50319,92211,670 
Debt195,000150,000150,000151,284  
Derivative instruments and hedges, liabilities 35,00032,282   
Due to related parties 210,384182,834152,234  
Other undisclosed current liabilities304,96753,04722,06113,789288,650189,092
Total current liabilities:679,411586,647479,623375,012300,320189,092
Noncurrent Liabilities
Total liabilities:679,411586,647479,623375,012300,320189,092
Equity
Equity, attributable to parent(679,116)(585,913)(478,730)(365,739)(267,824)(184,285)
Common stock1,1351,1351,13511,00011,000116,000
Additional paid in capital500,479500,479500,479484,414480,414385,414
Accumulated deficit(1,180,730)(1,087,527)(980,344)(861,153)(759,238)(685,699)
Total equity:(679,116)(585,913)(478,730)(365,739)(267,824)(184,285)
TOTAL LIABILITIES AND EQUITY:2957348939,27332,4964,807

Income Statement (P&L) (USD)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Operating expenses(47,303)(59,367)(75,141)(70,033)(53,981)(48,220)
Operating loss:(47,303)(59,367)(75,141)(70,033)(53,981)(48,220)
Nonoperating expense(45,900)(47,816)(44,050)(31,882)  
Interest and debt expense(45,900)(47,816)(44,050)(31,882)19,55816,003
Loss from continuing operations before equity method investments, income taxes:(139,103)(154,999)(163,241)(133,797)(34,423)(32,217)
Other undisclosed income from continuing operations before income taxes45,90047,81644,05031,882  
Loss from continuing operations:(93,203)(107,183)(119,191)(101,915)(34,423)(32,217)
Loss before gain (loss) on sale of properties:(107,183)(119,191)(101,915)(34,423)(32,217)
Other undisclosed net loss     (39,116)(32,006)
Net loss available to common stockholders, diluted:(93,203)(107,183)(119,191)(101,915)(73,539)(64,223)

Comprehensive Income (USD)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(93,203)(107,183)(119,191)(101,915)(73,539)(64,223)
Comprehensive loss, net of tax, attributable to parent:(93,203)(107,183)(119,191)(101,915)(73,539)(64,223)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: